Get the Stockscreener App
182.56
0.55%
0.99
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $182.56, with a volume of 1.14M.
It is up +0.55% in the last 24 hours and down -2.30% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$181.57
Open:
$182.16
24h Volume:
1.14M
Relative Volume:
1.10
Market Cap:
$20.31B
Revenue:
$10.52B
Net Income/Loss:
$999.00M
P/E Ratio:
21.83
EPS:
8.3628
Net Cash Flow:
$1.22B
1W Performance:
+0.03%
1M Performance:
-2.30%
6M Performance:
+1.97%
1Y Performance:
+16.97%
1-Day Range:
$181.23
$183.01
1-Week Range:
$178.61
$183.50
52-Week Range:
$148.70
$197.55
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
182.56 | 20.20B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-17-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-28-24 | Resumed | Evercore ISI | In-line |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Bayesian Capital Management LP Takes Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Looking Into Quest Diagnostics Inc's Recent Short Interest - Sahm
California Public Employees Retirement System Reduces Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Marshall Wace LLP Reduces Position in Quest Diagnostics Incorporated $DGX - MarketBeat
First Trust Advisors LP Sells 114,868 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Invesco Ltd. Raises Position in Quest Diagnostics Incorporated $DGX - MarketBeat
New York State Common Retirement Fund Sells 7,619 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Can Quest Diagnostics Incorporated (QDI) stock hold up in economic slowdownTrade Exit Report & Safe Entry Zone Identification - Newser
Will Quest Diagnostics Incorporated stock outperform benchmarksJuly 2025 Trends & Real-Time Chart Breakout Alerts - Newser
1,325,624 Shares in Quest Diagnostics Incorporated $DGX Purchased by Norges Bank - MarketBeat
Korea Investment CORP Purchases 12,300 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Published on: 2025-12-03 05:06:27 - Newser
Blueshift Asset Management LLC Has $636,000 Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Incorporated (QDI) stock ideal for retirement investorsPortfolio Performance Report & Daily Volume Surge Signals - Newser
Is Quest Diagnostics Incorporated stock nearing a technical breakoutExit Point & Expert Approved Momentum Ideas - Newser
Mackenzie Financial Corp Has $28.11 Million Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Schroder Investment Management Group Buys 122,646 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Incorporated stock cheap vs fundamentalsJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser
Why analysts maintain buy rating on Quest Diagnostics Incorporated stockBreakout Watch & Low Drawdown Momentum Ideas - Newser
Russell Investments Group Ltd. Acquires 25,768 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Published on: 2025-12-02 04:36:26 - Newser
How cyclical is Quest Diagnostics Incorporated stock compared to rivals2025 Analyst Calls & Real-Time Chart Breakout Alerts - Newser
Distillate Capital Partners LLC Sells 4,577 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Hsbc Holdings PLC Reduces Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - sharewise.com
Quest Diagnostics Inc. stock underperforms Monday when compared to competitors - MarketWatch
Quest Diagnostics, Octave Collaborate to Expand Multiple Sclerosis Disease Activity Test Access - marketscreener.com
Octave Bio lands massive deal with Quest Diagnostics that will expand reach of its multiple sclerosis tests - The Business Journals
Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave - Business Wire
First National Advisers LLC Purchases Shares of 8,980 Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Insider Sold Shares Worth $10,589,760, According to a Recent SEC Filing - marketscreener.com
Quest Diagnostics (NYSE: DGX) to offer Octave MSDA MS blood test at 7,000 U.S. sites - Stock Titan
Skandinaviska Enskilda Banken AB publ Raises Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
J. Davis Sells 55,093 Shares of Quest Diagnostics (NYSE:DGX) Stock - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Sold by Grantham Mayo Van Otterloo & Co. LLC - MarketBeat
Northwest & Ethical Investments L.P. Invests $1.10 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Stock Holdings Lifted by Franklin Resources Inc. - MarketBeat
Prudential Financial Inc. Grows Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Does Quest Diagnostics Offer Value After 8% Surge and New Partnerships in 2025? - Yahoo Finance
Insider Sell: Vicky Gregg Sells Shares of Quest Diagnostics Inc (DGX) - GuruFocus
Chmn Davis Sells 55,093 ($10.6M) Of Quest Diagnostics Inc [DGX] - TradingView
Dir Gregg Sells 1,250 ($239.7K) Of Quest Diagnostics Inc [DGX] - TradingView
Quest Diagnostics (DGX) CEO James E. Davis exercises options and sells common stock - Stock Titan
[Form 4] QUEST DIAGNOSTICS INC Insider Trading Activity - Stock Titan
Advisors Asset Management Inc. Reduces Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Acquired by Charles Schwab Investment Management Inc. - MarketBeat
Can Quest Diagnostics Incorporated stock deliver sustainable ROEQuarterly Profit Report & AI Driven Stock Price Forecasts - BỘ NỘI VỤ
HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet? - Finviz
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term - sharewise.com
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Boston Partners Has $545.32 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):